The Vigabatrin REMS Program is required by the FDA to make sure informed risk-benefit choices prior to launching treatment, and to make certain proper use of vigabatrin while patients are dealt with. When vision loss will certainly occur, it is not feasible for your health care supplier to recognize.
One of the most common negative effects of SABRIL in youngsters 3 to 16 years is weight gain. With serious vision loss, you might just be able to see points directly before you (often called tunnel vision"). You are at threat for vision loss with any amount of SABRIL.
If you are expectant or plan to get expecting, tell your health care supplier. If vision testing can not be done, your healthcare provider may proceed recommending SABRIL, yet will not be able to watch for any type of vision loss. Your healthcare company may quit recommending SABRIL for you (or your child)if vision examinations are not done frequently.